These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 963807)
1. [Treatment of schizophrenia using depot neuroleptics (author's transl)]. Faltus F; Soucek K Cesk Psychiatr; 1976 Jun; 72(3):170-5. PubMed ID: 963807 [No Abstract] [Full Text] [Related]
2. [The role of depot neuroleptics for the longterm treatment of schizophrenic patients (author's transl)]. Woggon B; Angst J Schweiz Rundsch Med Prax; 1977 Apr; 66(14):421-7. PubMed ID: 866293 [No Abstract] [Full Text] [Related]
3. [Depot neuroleptics - practical method of the longtime treatment and methodological problems of clinical trials (author's transl)]. Woggon B Ther Umsch; 1975 Aug; 32(8):501-6. PubMed ID: 1162636 [No Abstract] [Full Text] [Related]
4. [Prevention of relapse in the era of depot neuroleptics and social psychiatry]. Schindler R Nervenarzt; 1976 May; 47(5):347-50. PubMed ID: 179025 [No Abstract] [Full Text] [Related]
5. [What should the general practitioner know about the treatment of chronic schizophrenia with long-acting neuroleptics?]. Beier R; Friemert K; Vehreschild T Z Arztl Fortbild (Jena); 1973 Dec; 67(23):1206-7. PubMed ID: 4791840 [No Abstract] [Full Text] [Related]
6. [Experiences with depot neuroleptics]. Tettelaar CA Schweiz Rundsch Med Prax; 1973 Jun; 62(26):827-38. PubMed ID: 4579170 [No Abstract] [Full Text] [Related]
7. [Long-term treatment of outpatients with depot neuroleptics (author's transl)]. Saameli W Schweiz Rundsch Med Prax; 1981 Feb; 70(6):206-10. PubMed ID: 6113584 [No Abstract] [Full Text] [Related]
8. [Depot-neuroleptics]. van Praag HM Ned Tijdschr Geneeskd; 1971 Apr; 115(15):672-3. PubMed ID: 5551425 [No Abstract] [Full Text] [Related]
9. [Possibilities and limits of depot neuroleptic therapy of schizophrenic psychoses]. Glatzel J Ther Ggw; 1970 Jun; 109(6):834-6 passim. PubMed ID: 5453883 [No Abstract] [Full Text] [Related]
10. [Long-term treatment with neuroleptics in schizophrenic and paraphrenic psychoses]. König L Z Arztl Fortbild (Jena); 1977 Apr; 71(8):410-4. PubMed ID: 878514 [No Abstract] [Full Text] [Related]
11. [Experiences with the depot-neuroleptic agent Dapotum D]. Teutsch H; Boissi KW Med Welt; 1974 Nov; 25(48):2027-32. PubMed ID: 4459664 [No Abstract] [Full Text] [Related]
12. [Effects of depot neuroleptics on pituitary hormone secretion (author's transl)]. Czernik A; Kleesiek K Nervenarzt; 1979 Aug; 50(8):527-33. PubMed ID: 43482 [No Abstract] [Full Text] [Related]
15. The depot compounds moditen (fluphenazine) and IMAP (fluspirilene) in clinical practice. Faltus F Act Nerv Super (Praha); 1974 Aug; 16(3):167-8. PubMed ID: 4607824 [No Abstract] [Full Text] [Related]
16. [Clinical treatment of chronic psychoses with flupenthixol-decanoate (Fluanxol-Depot)]. Gross H; Kaltenbäck E Wien Klin Wochenschr; 1972 Feb; 84(5):80-4. PubMed ID: 5015880 [No Abstract] [Full Text] [Related]
17. [Treatment of schizophrenic psychoses by sustained-action neuroleptics in psychiatric outpatients' treatment (author's transl)]. Polácek J Cesk Psychiatr; 1982 Feb; 78(1):49-55. PubMed ID: 7060182 [No Abstract] [Full Text] [Related]
18. [Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)]. Bruck J; Guss H Int Pharmacopsychiatry; 1974; 9(3):152-65. PubMed ID: 4154320 [No Abstract] [Full Text] [Related]
19. [Oral glucose tolerance test in schizophrenics under long-term neuroleptic treatment (author's transl)]. Gonçalves N; Grüneberg F Pharmakopsychiatr Neuropsychopharmakol; 1975 Sep; 8(5):289-95. PubMed ID: 1233523 [TBL] [Abstract][Full Text] [Related]